Related content

Vaccination with an adenoviral vector expressing calreticulin-human papillomavirus 16 E7 fusion protein eradicates E7 expressing established tumors in mice

By Gomez-Gutierrez Jorge   Elpek Kutlu   Montes de Oca-Luna Roberto   Shirwan Haval   Sam Zhou H.   McMasters Kelly  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 7, 2007-07 ,pp. : 997-1007

Springer Publishing Company

Access to resources Recommend Favorite

Genetic stability of a recombinant adenovirus vaccine vector seed library expressing human papillomavirus type 16 E6 and E7 proteins

By                  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 4, 2015-01 ,pp. : 1161-1165

Spandidos Publications

Access to resources Recommend Favorite

Interactions of the human papillomavirus E7 protein with cell cycle regulators

By Jones D.L.   Munger K.  

Seminars in Cancer Biology, Vol. 7, Iss. 6, 1996-12 ,pp. : 327-337

Academic Press

Access to resources Recommend Favorite

High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia

By Persson Maria   Brismar Wendel Sophia   Ljungblad Linda   Johansson Bo   Weiderpass Elisabete   Andersson Sonia  

Oncology Reports, Vol. 28, Iss. 1, 2012-07 ,pp. : 346-352

Spandidos Publications

Access to resources Recommend Favorite

Relevance of infection with human papillomavirus: The role of the p53 tumor suppressor protein and E6/E7 zinc finger proteins (Review)

By Ruttkay-Nedecky Branislav   Jimenez Jimenez Ana Maria   Nejdl Lukas   Chudobova Dagmar   Gumulec Jaromir   Masarik Michal   Adam Vojtech   Kizek Rene  

International Journal of Oncology, Vol. 43, Iss. 6, 2013-12 ,pp. : 1754-1762

Spandidos Publications

Access to resources Recommend Favorite